Wendy B. Young serves as Executive at Rapport Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Wendy B. Young has executed 1 insider transactions totaling $79.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 11, 2025 involved purchasing 3,500 shares valued at $79.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 11, 2025 | RAPP | $79.1K | Purchase | 3,500 | $22.60 | Discretionary |
Wendy B. Young currently holds 9,500 shares of Rapport Therapeutics, Inc. (RAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendy B. Young has been a net buyer of RAPP stock. They have purchased $79.1K and sold $0 worth of shares.
Wendy B. Young's most recent insider trade was on Sep 11, 2025, when they purchased 3,500 shares at $22.60 per share.
Get notified when new Form 4 filings are submitted